In the news / Drug Discovery

NEWS
UArizona researchers are responsible for an amazing breakthrough in how we treat cancer. This breakthrough is designed for cancer patients for whom current immunotherapies are ineffective. That includes 96% of all colorectal cancer patients. It also boosts existing treatments without increasing toxicity.
 
NEWS
In the summer of 2021, the FDA approved the first new medication for Alzheimer’s Disease in 18 years. Mark talks with Roberta Diaz Brinton PhD, Director of the UA Center for Innovation in Brain Science and a Professor of Pharmacology & Neurology in the UA College of Medicine. Brinton's team discovered an important link between estrogen levels and a reduced risk for developing Alzheimer’s disease.
 
NEWS
A new UArizona Health Sciences Workforce Education and Training Program, PeerWORKS, has been designed to help people impacted by opioid and substance use disorders. The program will train state-certified health professionals, who are in recovery from a mental illness or substance use disorder, to provide support to those experiencing similar issues.
 
NEWS
We're only beginning to understand all the different types of chemicals that can be found in the Cannabis sativa plant, and CBD is one of them. Dr. Todd Vanderah addresses what you need to know if you are thinking about trying CBD.
 
NEWS
The third annual Drug Discovery and Development Summit aims to foster private-public collaboration and commercialization of new discoveries against diseases most burdensome to Arizonans.
 
NEWS
More than 1.5 billion people live with chronic pain worldwide, and it’s the most common cause of long-term disability in the United States. Several BIO5 researchers are addressing chronic pain and working to tackle the opioid epidemic through basic science and clinical approaches.
 
NEWS
The finalists of the 2021 Copper Cactus Awards have been announced including UArizona innovators from Avery Therapeutics, SaiOx, and uPetsia. The awards ceremony will be held on October 1, 2021.
 
NEWS
The Comprehensive Pain and Addiction Center will oversee PeerWORKS, which is a collaboration between UArizona COM-T, the Mel and Enid Zuckerman College of Public Health, and the Center for Rural Health and the Workforce Development Program. The center received a $2.2M grant to train peer support specialists to serve in integrated care facilities in rural and underserved areas of Arizona.
 
NEWS
The FDA has approved ivosidenib Tablets (Tibsovo) for the treatment of patients with IDH1-mutant cholangiocarcinoma, as detected by an FDA-approved test, according to a press release issued by Servier Pharmaceuticals. This medication, according to Dr. Rachna Shroff of the UArizona Cancer Center, would provide a new treatment for patients.
 
NEWS
Cholangiocarcinoma is a rare, aggressive cancer affecting the bile ducts both in and outside of the liver. Experts estimate that 8000 people in the United States are diagnosed with this cancer each year, although the actual number is likely to be higher because it can be hard to diagnose and may be misclassified as other types of cancer.
 
NEWS
A recent UArizona College of Pharmacy study suggests that personal genomic educational testing (PGET), which is thought to have potential as a learning tool in pharmacogenomic education, may offer no significant benefits in terms of improved knowledge or attitudes for PharmD students towards the subject.
 
NEWS
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
 
NEWS
Dr. Jianqin Lu leads a research team which created the first nanotherapeutic platform of its kind, using a nanotechnology delivery method to make them more effective against aggressive tumors. The researchers note that their nanotechnology platform can be used to deliver a range of cancer therapeutics.
 
NEWS
Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions. In the last fiscal year alone UArizona received 274 invention disclosures and launched 17 startups.
 
NEWS
Despite slowdowns in research suffered by universities around the world due to the pandemic, the University of Arizona has experienced solid growth in the commercialization of university inventions.
 
NEWS
A team of University of Arizona researchers are changing the way we prevent and treat heart disease. Dr. Chris Glembotski discovered a compound shown to be effective in reducing severity and recurrence of heart attack, even limiting the damage to the brain during stroke.
 
NEWS

Sleep is a big deal, and we’re not getting enough. An estimated 50 to 70 million Americans are affected by poor sleep and it’s having an impact on both our mental and physical health.

 
NEWS
The National Academy of Inventors has named 61 academic inventors to the 2021 class of NAI Senior Members. Among them are University of Arizona Health Sciences professors Drs. May Khanna and Meredith Hay. NAI Senior Members are active faculty, scientists and administrators from NAI Member Institutions who have demonstrated remarkable innovation producing technologies that have brought, or aspire to bring, real impact on the welfare of society.